StockData
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31

TALPHERA, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.08+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$81.57M
P/E (TTM)
–
Dividend yield
–

TALPHERA, INC. revenue by segment

By business segment

By product or service

RevenueFY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
Product [Member]$1.77M$1.01M$2.52M$1.83M$825.00K$6.67M––+76.2%
DSUVIA [Member]$1.59M$735.00K$1.41M–––––+116.1%
DZUVEO [Member]$183.00K$0–––––––
Contract and Other Collaboration [Member]$0$1.81M$2.90M$459.00K$1.33M$1.32M––-100.0%
ZALVISO [Member]$0$270.00K$1.11M$1.45M$825.00K$6.67M––-100.0%
Non-cash Royalty [Member]$0$83.00K$242.00K$312.00K$289.00K$151.00K––-100.0%
Contract and Other Revenue [Member]$0$6.00K$2.57M$43.00K$103.00K$269.00K––-100.0%
Royalty [Member]$0$28.00K$81.00K$104.00K$96.00K–––-100.0%
License [Member]$0$1.70M$0–––––-100.0%
Collaboration Agreement Revenue [Member]––––$1.31M$7.14M$6.44M––
Contract and Other [Member]––––$838.00K$852.00K$10.92M––
Royalty Revenue [Member]––––$96.00K$50.00K–––
Department of Defense [Member]––$0$0$838.00K$852.00K–––
Amended License Agreement [Member]––$3.68M$1.50M$928.00K––––
DSUVIA [Member]––$1.41M$377.00K$0––––

By region

From the segment and revenue-disaggregation notes of Talphera's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.